Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2002
05/02/2002CA2431178A1 Baseb209 polypeptides and polynucleotides from haemophilus influenzae
05/02/2002CA2429044A1 Secreted alpha-helical cytokine-like protein zlmda24
05/02/2002CA2427312A1 Engineered chimera of protein fragments and methods of use thereof
05/02/2002CA2427085A1 Transmembrane proteins
05/02/2002CA2427070A1 Preferred segments of neural thread protein and methods of using the same
05/02/2002CA2427005A1 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
05/02/2002CA2426887A1 Polypeptides and polynucleodides from haemophilus influenzae and their use
05/02/2002CA2426859A1 A functional assay for g-protein-coupled receptors based on insect cells
05/02/2002CA2426767A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
05/02/2002CA2426742A1 Haemophilus influenzae basb210 polypeptides and encoding polynucleotides and uses thereof
05/02/2002CA2426738A1 Streptococcal genes
05/02/2002CA2426736A1 Vegf peptides and their use for inhibiting angiogenesis
05/02/2002CA2426647A1 Expression vectors and uses thereof
05/02/2002CA2426405A1 Estrogen receptor alpha variants and methods of detection thereof
05/02/2002CA2426321A1 Mfq-114, a human ajuba like protein
05/02/2002CA2426294A1 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications
05/02/2002CA2426094A1 Amyloid precursor protein and app-derived peptides inhibit tumor growth and metastasis
05/02/2002CA2425897A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
05/02/2002CA2425770A1 Using heat shock proteins to increase immune response
05/02/2002CA2425303A1 Nucleic acids and proteins from streptococcus groups a & b
05/02/2002CA2425000A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections
05/02/2002CA2422899A1 Protein data analysis
05/02/2002CA2421679A1 Monocotyledon plant cells and plants which synthesise modified starch
05/01/2002CN1347458A Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences
05/01/2002CN1347456A Collagen-binding physiologically active polypeptide
05/01/2002CN1347453A Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
05/01/2002CN1347449A 芽孢杆菌蛋白生产细胞 Bacillus cell protein production
05/01/2002CN1347327A Methods for glucagon suppression
05/01/2002CN1347326A BAFF, inhibitors thereof and their use in modulation of B-cell response
05/01/2002CN1346831A Purified polypeptide with bioactivity and medicine prepared from it for promoting growth and development of animal's nerve cells and suppressing their apotosis
04/2002
04/30/2002US6380463 Gene expression cassette
04/30/2002US6380459 Compositions and methods for the modification of gene expression
04/30/2002US6380458 Genetic engineering; forming hybrids
04/30/2002US6380382 Isolated nucleic acid
04/30/2002US6380377 Nucleic acid hairpin probes and uses thereof
04/30/2002US6380376 Purity polypeptides
04/30/2002US6380375 DNA encoding monkey gonadotropin releasing hormone receptor
04/30/2002US6380374 Isolated nucleic acid; culture product
04/30/2002US6380373 Isolated nucleic acid
04/30/2002US6380372 Barley gene for Thioredoxin and NADP-thioredoxin reductase
04/30/2002US6380371 Endoglycan: a novel protein having selectin ligand and chemokine presentation activity
04/30/2002US6380369 Human DNA mismatch repair proteins
04/30/2002US6380365 Temperature dependent ligand facilitated purification of proteins
04/30/2002US6380364 Complexing; genetic engineering
04/30/2002US6380363 Antibodies to the Ob receptor
04/30/2002US6380362 Genetic engineering
04/30/2002US6380361 Educational kit and method containing novel alpha helical protein-34
04/30/2002US6380360 Polycystic kidney disease 1 gene and uses thereof
04/30/2002US6380359 Liposomes comprising peptide antigens derived from X protein of hepatitis B virus
04/30/2002US6380357 Solution comprises purified glucagon-like peptide-1, buffering agent containing alcohol or mono/di- saccharide, and optionally ammonium sulfate; tetragonal flat rod shaped crystals formed; useful in treating diabetes and obesity
04/30/2002US6380355 Process for obtaining insulin precursors having correctly bonded cystine bridges
04/30/2002US6380354 A proteinase inhibitor protein; therapy and diagnosis thromobosis, coagulation disorders and inflammation
04/30/2002US6380170 Nucleic acid construct for the cell cycle regulated expression of structural genes
04/30/2002US6380162 Ice inhibiting peptides
04/30/2002US6380161 Therapy of cancer, wherein a cancer chemotherapy agent is selected, conjugated to peptide, and one dose is administered to patient in therapeutically effective amount, and wherein peptide binds to a receptor for thrombospondin
04/30/2002US6380160 Gp130 lacking the transmembrane domain
04/30/2002US6380159 Genes for male accessory gland proteins in drosophila melanogaster
04/30/2002US6380158 Motilin homologs
04/30/2002US6380157 Administering medicament comprising papillomavirus l2 protein, or a therapeutically effective fragment thereof for therapy of papillomavirus infection
04/30/2002US6380154 Synthetic proteins for in vivo drug delivery and tissue augmentation
04/30/2002US6379975 Methods and reagents for determining protein S
04/30/2002US6379967 A mutant viral gene that prevents viral replication in human cells; gene therapy
04/30/2002US6379965 Nucleic acid noncovalently associated with a polyamine compound that is covalently attached to an endosome disrupting agent such as cholic acid; nonviral vectors
04/30/2002US6379961 Stimulating neural crest cell differentiation in culture by administering an amount of a purified bone morphogenetic protein
04/30/2002US6379959 An isolated protease inhibitor; antitumor, anticarcinogenic agents
04/30/2002US6379953 An activated leukocyte cell adhesion molecule bearing mesenchymal stem cell; for accelerating differentiation of bone morphogenic proteins; bone repair therapy
04/30/2002US6379951 Compounds for immunotherapy of breast cancer and methods for their use
04/30/2002US6379946 Insecticidal protein toxins from Xenorhabdus
04/30/2002US6379945 Gene switch
04/30/2002US6379944 A recombinant cell that is permissive for replication of a bovine adenovirus vector; for preparing viable recombinant virus vaccines; gene therapy
04/30/2002US6379927 Retinoblastoma fusion proteins
04/30/2002US6379926 Polynucleotides encoding chemokine β-6 antagonists
04/30/2002US6379925 Angiogenic modulation by notch signal transduction
04/30/2002US6379924 Amplifying protein products by using fungal cells having a plasmid with a funcional coding sequence and also having a modified level of ubiquitin conjugating enzymes activity; then culturing the cell to produce a fungal derived product
04/30/2002US6379923 ELL2, a new member of an ELL family of RNA polymerase II elongation factors
04/30/2002US6379912 Motor proteins and method for their use
04/30/2002US6379906 A method to determine a mature tapeworm from the larval form by mixing a biological sample with an adult specific excretory/secretory polypeptide; detecting binding as an indicator of an adult tapeworm infection
04/30/2002US6379905 Fragments of prion proteins
04/30/2002US6379904 A purified human particularly interesting new cysteine histidine protein homolog; for diagnosis, therapy and preventing cancer and reproductive disorders
04/30/2002US6379903 Purification of recombinant proteins fused to multiple epitopes
04/30/2002US6379902 Mycrobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis
04/30/2002US6379901 Detecting cancer cells that express a human leukocyte antigen molecule using a nonapeptide derived from the tumor rejection antigen precursor; mixing cells and nonapeptide to form complexes; expose to cytolytic cells and determine lysis
04/30/2002US6379894 Method for screening compounds capable of inhibiting binding between the transcription factor of STAT1 and the transcription factor of USF1
04/30/2002US6379891 A polymerase chain reaction amplification method for detecting enterically transmitted non-a/non-b viral hepatitis in a biological sample
04/30/2002US6379887 A polynucleotide; used in cosmetic and dermatology development
04/30/2002US6379886 Diagnostic regeant for hepatitis C virus infection
04/30/2002US6379885 Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
04/30/2002US6379701 Controlled release of metal cation-stabilized interferon
04/30/2002US6379699 Liposome having attached target-binding moiety and artherosclerotic plaque interacting moiety
04/30/2002US6379693 Trivalent chromium complex compound and milk product containing the same
04/30/2002US6379690 A tissue engineering cell scaffold for engineering bone tissue comprising a keratin hydrogel comprising reformed keratin-to keratin disulfide links; keratin derived from human hair; nonantigenic wound healing agent
04/30/2002US6379679 Genetic engineering; viricides
04/30/2002US6379678 Culture product; antiallergens
04/30/2002US6379677 Streptococcus iniae vaccine
04/30/2002US6379675 Immunological combination compositions and methods
04/30/2002US6379671 Using a polypeptide antigen mixture
04/30/2002US6379670 Administering a genetic engineering polypeptide
04/30/2002US6379665 Therapy for rheumatic diseases; antiarthritic agents
04/30/2002US6379662 Human interleukin variation
04/30/2002US6379661 Pharmaceutical compositions comprising pluripotent granulocyte colony-stimulating factor